Nanosonics Limited (NNCSF)
USD 1.75
(0.0%)
USD 1.75
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 12.97 Million AUD | -34.76% |
| 2023 | 19.88 Million AUD | 431.35% |
| 2022 | 3.74 Million AUD | -56.38% |
| 2021 | 8.57 Million AUD | -15.38% |
| 2020 | 10.13 Million AUD | -25.47% |
| 2019 | 13.6 Million AUD | 136.52% |
| 2018 | 5.75 Million AUD | -78.01% |
| 2017 | 26.15 Million AUD | 21340.98% |
| 2016 | 122 Thousand AUD | 102.23% |
| 2015 | -5.46 Million AUD | -109.6% |
| 2014 | -2.6 Million AUD | 54.84% |
| 2013 | -5.76 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | 12.97 Million AUD | -34.76% |
| 2024 Q4 | 3.4 Million AUD | 0.0% |
| 2024 Q1 | 3.08 Million AUD | -67.58% |
| 2024 Q2 | 6.16 Million AUD | 100.0% |
| 2024 Q3 | 3.4 Million AUD | -44.84% |
| 2023 Q2 | 10.36 Million AUD | 100.0% |
| 2023 Q4 | 9.51 Million AUD | 100.0% |
| 2023 Q1 | 5.18 Million AUD | 3998.12% |
| 2023 FY | 19.88 Million AUD | 431.35% |
| 2023 Q3 | 4.75 Million AUD | -54.12% |
| 2022 Q2 | 3.87 Million AUD | 100.0% |
| 2022 Q4 | -133 Thousand AUD | -100.0% |
| 2022 FY | 3.74 Million AUD | -56.38% |
| 2022 Q1 | 1.93 Million AUD | -72.76% |
| 2022 Q3 | -66.5 Thousand AUD | -101.72% |
| 2021 FY | 8.57 Million AUD | -15.38% |
| 2021 Q3 | 3.55 Million AUD | 142.96% |
| 2021 Q4 | 7.11 Million AUD | 100.0% |
| 2021 Q1 | 732 Thousand AUD | -83.46% |
| 2021 Q2 | 1.46 Million AUD | 100.0% |
| 2020 Q4 | 4.42 Million AUD | 100.0% |
| 2020 FY | 10.13 Million AUD | -25.47% |
| 2020 Q1 | 2.85 Million AUD | -12.1% |
| 2020 Q2 | 5.71 Million AUD | 100.0% |
| 2020 Q3 | 2.21 Million AUD | -61.25% |
| 2019 Q4 | 3.24 Million AUD | 0.0% |
| 2019 Q1 | 3.55 Million AUD | 100.82% |
| 2019 Q2 | 3.55 Million AUD | 0.0% |
| 2019 Q3 | 3.24 Million AUD | -8.56% |
| 2019 FY | 13.6 Million AUD | 136.52% |
| 2018 Q3 | 1.76 Million AUD | 59.87% |
| 2018 FY | 5.75 Million AUD | -78.01% |
| 2018 Q1 | 1.1 Million AUD | -46.97% |
| 2018 Q2 | 1.1 Million AUD | 0.0% |
| 2018 Q4 | 1.76 Million AUD | 0.0% |
| 2017 Q1 | 10.99 Million AUD | 552.96% |
| 2017 Q4 | 2.08 Million AUD | 0.0% |
| 2017 FY | 26.15 Million AUD | 21340.98% |
| 2017 Q3 | 2.08 Million AUD | -81.02% |
| 2017 Q2 | 10.99 Million AUD | 0.0% |
| 2016 Q1 | -1.62 Million AUD | 51.55% |
| 2016 Q4 | 1.68 Million AUD | 0.0% |
| 2016 Q3 | 1.68 Million AUD | 203.76% |
| 2016 Q2 | -1.62 Million AUD | 0.0% |
| 2016 FY | 122 Thousand AUD | 102.23% |
| 2015 Q1 | 619 Thousand AUD | 41.16% |
| 2015 FY | -5.46 Million AUD | -109.6% |
| 2015 Q4 | -3.34 Million AUD | 0.0% |
| 2015 Q3 | -3.34 Million AUD | -641.03% |
| 2015 Q2 | 619 Thousand AUD | 0.0% |
| 2014 Q2 | -1.74 Million AUD | 0.0% |
| 2014 Q4 | 438.5 Thousand AUD | 0.0% |
| 2014 Q3 | 438.5 Thousand AUD | 125.19% |
| 2014 Q1 | -1.74 Million AUD | -1444.4% |
| 2014 FY | -2.6 Million AUD | 54.84% |
| 2013 Q3 | 129.5 Thousand AUD | 104.3% |
| 2013 FY | -5.76 Million AUD | 0.0% |
| 2013 Q1 | -3.01 Million AUD | 0.0% |
| 2013 Q2 | -3.01 Million AUD | 0.0% |
| 2013 Q4 | 129.5 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 1499.514% |
| Ansell Limited | 76.5 Million USD | 83.043% |
| Ansell Limited | 76.5 Million USD | 83.043% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 46.574% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 895.71% |
| Psykey, Inc. | -1.32 Million USD | 1079.795% |
| ConvaTec Group Plc | 130.3 Million USD | 90.045% |
| ConvaTec Group Plc | 130.3 Million USD | 90.045% |
| Encision Inc. | -691.78 Thousand USD | 1975.154% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 9247.386% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 5634.933% |
| Innovative MedTech Inc. | -7.93 Million USD | 263.398% |
| LifePoint, Inc. | -15.23 Million USD | 185.165% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 290.457% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 2836.709% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 4826.613% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 2925.971% |
| SmileDirectClub, Inc. | -86.4 Million USD | 115.013% |
| Sector 10, Inc. | 7036.00 USD | -184266.117% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 99.352% |
| SheerVision, Inc. | -71.37 Thousand USD | 18274.176% |
| United Health Products, Inc. | -2.62 Million USD | 594.498% |
| Vasamed, Inc. | -4.88 Million USD | 365.376% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 643.11% |
| Yubo International Biotech Limited | -1.2 Million USD | 1176.725% |